Eli Lilly Stock Surges on Obesity Treatment Outlook

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded10 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2198366

Show notes

Eli Lillys stock surged following Leerink Partners upgrade to Outperform, raising price target to $1,104, driven by anticipated obesity treatment adoption and Medicare/Medicaid expansion. Shares closed at $969.48, a 4.9% increase, marking a new fifty-two-week high and a 24.6% YTD gain. Long-term investors have seen a sixfold return over five years.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.